Our data instead support the role of MPI, at physiological concentrations of mannose, as an enzyme important in supporting AML cells survival following therapy through its ability to modulate MM, protein glycosylation and activity of the ATF6 arm of the UPR. Here, MPI is linked to Miyoshi myopathy.